Back

The impact of genetic mutations on ventricular tachycardia substrate types and ablation outcome in patients with non ischemic cardiomyopathy

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Young Investigator Awards - Clinical Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Micaela Ebert

Heart Center - University Hospital Dresden, Dresden (Germany)

5 More presentations in this session

Presentation thumbnail
Outcomes of a nationwide screening program for silent arrythmogenic cardiovascular disease in young individuals
Doctor H. Dhutia (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Risk of sudden infant death syndrome (SIDS) among siblings of SIDS victims: a Danish nationwide cohort study
Doctor C. Glinge (Copenhagen, DK)
Abstract
Presentation thumbnail
Are recurrences of post MI VT due to substrate progression of insufficient index ablation? A 4 years FU study
Doctor A. Lam (Thun, CH)
Abstract Slides Video
Presentation thumbnail
Wide area left atrial appendage isolation for atrial fibrillation therapy: Long-term succes and incidence of stroke and thrombus formation
Doctor C. Heeger (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Whole human heart histology to evaluate the performance of bipolar and unipolar voltage mapping in the detection of fibrosis in patients with non-ischemic cardiomyopathy and ventricular tachycardia
Ms C. Glashan (Leiden, NL)
Abstract

Access the full session

Session thumbnail
Young Investigator Awards - Clinical

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources